A phase I/II, open-label study to evaluate the safety, tolerance and pharmacokinetics of stavudine (d4T) in combination with lamivudine (3TC) in HIV-infected pregnant women and their infants

Trial Profile

A phase I/II, open-label study to evaluate the safety, tolerance and pharmacokinetics of stavudine (d4T) in combination with lamivudine (3TC) in HIV-infected pregnant women and their infants

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2012

At a glance

  • Drugs Lamivudine (Primary) ; Stavudine (Primary) ; Zidovudine
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top